International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease
Therapeutic Advances in Gastroenterology
Published online on June 29, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Pyoderma gangrenosum (PG) is a rare but challenging extraintestinal manifestation (EIM) of inflammatory bowel diseases (IBD), affecting 6%–48% of IBD patients. This retrospective study analyzed affected patients and evaluated therapeutic strategies for ...
Pyoderma gangrenosum (PG) is a rare but challenging extraintestinal manifestation (EIM) of inflammatory bowel diseases (IBD), affecting 6%–48% of IBD patients. This retrospective study analyzed affected patients and evaluated therapeutic strategies for ...